[Control of SARS-CoV-2 in prisons].
El control de la infección por SARS-CoV-2 en prisiones.
Control de riesgo
Coronavirus infections
Health surveillance
Infecciones por coronavirus
Prevención y control
Prevention & control
Prisiones
Prisons
Risk management
SARS-CoV2
Vigilancia sanitaria
Journal
Semergen
ISSN: 1578-8865
Titre abrégé: Semergen
Pays: Spain
ID NLM: 9610769
Informations de publication
Date de publication:
Historique:
received:
27
10
2020
accepted:
30
10
2020
pubmed:
29
12
2020
medline:
11
2
2021
entrez:
28
12
2020
Statut:
ppublish
Résumé
Review of control and management of SARS-CoV-2 infection in penitentiary institutions in Spain and other countries. A systematic review a comprehensive literature search in Global Health, SCOPUS, Medline and EMBASE was performed using relevant keywords and medical descriptors (MeSH) related to the coronavirus disease (COVID-19) and prisons. National and international recommendations and guides were examined as well as documents published by some countries. The key points of the guides are discussed. The vast majority of recommendations coincide with respect to the measures and procedures that should be used, except for some discrepancy regarding the population screening. Until now, most industrialized countries (except the US and some specific scenarios) have controlled successfully the epidemic in prisons. Less data is found as regards to socioeconomically more disadvantaged countries. Prisons are prone to a high risk of SARS-CoV-2 transmission due to their space limitations and sometimes poor environmental and hygienic conditions. The recommendations of the control and management of SARS-CoV-2 infection must be the same as those outside the prison, but must be adapted to the peculiarities of the prison. The recommendations must be issued by the health administration in coordination with the prison administration. Finally, must be abide by the Mandela Rules or by the Standard Minimum Rules for the treatment of United Nations prisoners.
Identifiants
pubmed: 33358541
pii: S1138-3593(20)30407-X
doi: 10.1016/j.semerg.2020.10.009
pmc: PMC7698685
pii:
doi:
Types de publication
Journal Article
Review
Langues
spa
Sous-ensembles de citation
IM
Pagination
47-55Informations de copyright
Copyright © 2020 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.
Références
Lancet Public Health. 2020 Apr;5(4):e188-e189
pubmed: 32197116
Int J Infect Dis. 2020 Apr;93:201-204
pubmed: 32097725
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Rev Esp Sanid Penit. 2020 May-Aug;22(2):55-57
pubmed: 32697274
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
J Med Microbiol. 2003 Aug;52(Pt 8):715-720
pubmed: 12867568
mSystems. 2020 Apr 7;5(2):
pubmed: 32265315
Rev Esp Sanid Penit. 2012 Feb;14(3):106-13
pubmed: 23165634
Rev Esp Sanid Penit. 2012;14(1):19-27
pubmed: 22437905
BMJ. 2020 Apr 2;369:m1362
pubmed: 32241756
JAMA. 2020 Aug 11;324(6):602-603
pubmed: 32639537
J Hosp Infect. 1999 Jan;41(1):51-7
pubmed: 9949965
J R Soc Med. 2003 Aug;96(8):374-8
pubmed: 12893851
Am J Public Health. 2020 Jul;110(7):967-968
pubmed: 32352850
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Rev Esp Sanid Penit. 2016 Dec;18(3):73-75
pubmed: 27831594
Respirology. 2003 Nov;8 Suppl:S2-5
pubmed: 15018125
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
Infect Dis Model. 2020 Feb 29;5:264-270
pubmed: 32190785
Rev Bras Epidemiol. 2010 Dec;13(4):641-50
pubmed: 21180853
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930